Discovery of biomarkers in rare diseases: innovative approaches by predictive and personalized medicine.

Authors:
Gülbakan B; Özgül RK; Yüzbaşıoğlu A; Kohl M; Deigner HP and 1 more

Journal:
EPMA J

Publication Year: 2016

DOI:
10.1186/s13167-016-0074-2

PMCID:
PMC5143439

PMID:
27980697

View on PubMed View on PMC View Publisher
Journal Information

Full Title: EPMA J

Abbreviation: EPMA J

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Medicine, Research & Experimental

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Promoting advanced medical services in the framework of 3PM-a proof-of-concept by the "Centro" Regi…
Regateiro FJ; Silva H; Lemos MC and 7 more (2024) - Transparency Score: 3/6
Artificial intelligence to improve ischemia prediction in Rubidium Positron Emission Tomography-a v…
Frey SM; Bakula A; Tsirkin A and 13 more (2023) - Transparency Score: 3/6
Identification of potential necroinflammation-associated necroptosis-related biomarkers for delayed…
Bi Q; Wu JY; Qiu XM and 4 more (2023) - Transparency Score: 3/6
Integrating oculomics with genomics reveals imaging biomarkers for preventive and personalized pred…
Huang Y; Li C; Shi D and 16 more (2023) - Transparency Score: 4/6
Mechanical power normalized to aerated lung predicts noninvasive ventilation failure and death and …
Musso G; Taliano C; De Iuliis M and 9 more (2023) - Transparency Score: 2/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests The authors declare that they have no competing interests."

Evidence found in paper:

"GB (BIDEB-2232 programme) and ÖRK (SBAG, grand no. 213S006) acknowledge the financial support of TUBITAK, Turkey. ÖM was supported by Hacettepe Research Fund (THD-2015-7301)."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025